Try our corporate solution for free!
+1 (212) 419-5770

Pharmaceutical products in pipeline for disease in developing countries 2018

This statistic displays the distribution of pharmaceutical products along the pipeline for various diseases in developing countries, by disease category, as of 2018. At this time, 4.3 percent of products along the research and development pipeline were targeted towards neglected tropical diseases. Most products currently being developed are for non-communicable diseases. Products focusing on diabetes, lower respiratory infections, hepatitis, and malaria are important in the pharmaceutical industry.

Distribution of product pipeline for diseases in developing countries by category as of 2018*

Loading statistic...
You need to log in to download this statistic
Register for free
Already a member?
Log in
Show detailed source information?
Register for free
Already a member?
Log in

Release date

November 2018



Survey time period


Supplementary notes

* All values were calculated based on given numbers. Projects and products falling into multiple disease categories are counted twice.
** The 11 communicable diseases with the highest DALY burdens in countries in scope of the 2018 Index. The R&D pipeline includes 10 further diseases and 12 pathogens.

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Single Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract; Prices do not include sales tax.

Statistics on "Pharmaceutical industry in Norway "

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.